PHARMING GROUP NV (PHARM.AS)
NL0010391025 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 198.871M -6.27% | 205.622M 3.39% | 245.316M 19.30% | 296.56M 20.89% | 329.63M 11.15% | 371.47M 12.69% | 436.07M 17.39% | 394.54M -9.52% | 451.64M 14.47% | |
| EBITDA YoY % growth | 43.61M -48.43% | 23.555M -45.99% | -5.825M -124.73% | -2.318M 60.21% | 22.403M 1,066.69% | 69.68M 211.03% | 85.404M 22.57% | 121.96M 42.80% | N/A | |
| EBIT YoY % growth | 24M -68.53% | 10.367M -56.80% | -21.75M -309.80% | -9.471M 56.46% | 3.033M 132.02% | 26.425M 771.25% | 36.192M 36.96% | 48.219M 33.23% | 158.93M 229.60% | |
| Operating Margin | 12.07% | 5.04% | -8.87% | -3.19% | 0.92% | 7.11% | 8.30% | 12.22% | 35.19% | |
| EPS YoY % growth | 0.02 -55.95% | N/A 101.60% | -0.02 -132.92% | -0.01 31.31% | -0.01 8.62% | 0.02 305.13% | 0.06 204.00% | 0.12 93.26% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.01 357.50% | -0.01 45.79% | 0.00 100.00% | -0.01 -415.00% | 0.01 |
| Revenue Q2Q % growth | 84.063M 3.50% | 65.92M 18.59% | 83.43M 12.60% | 86.52M 15.59% | 94.142M 11.99% |
| EBITDA Q2Q % growth | 11.227M -33.94% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 5.253M 391.39% | -9.27M 43.17% | -3.811M -22.11% | -7.107M -273.00% | 4.635M -11.76% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.00 -140.00% | 0.00 | 0.00 | 22.33% |
| Q2 2024 Q2Q % growth | -0.01 | 0.01 | -0.02 | -197.09% |
| Q1 2024 Q2Q % growth | -0.02 -11.76% | 0.01 | -0.03 | -363.52% |
| Q4 2023 Q2Q % growth | 0.00 80.00% | 0.01 | -0.01 | -138.83% |
| Q3 2023 Q2Q % growth | 0.01 -61.54% | -0.03 | 0.03 | 118.67% |
| Q2 2023 Q2Q % growth | 0.00 -100.00% | -0.01 | 0.01 | 100.00% |
| Q1 2023 Q2Q % growth | -0.02 -440.00% | -0.01 | -0.01 | -153.92% |
| Q4 2022 Q2Q % growth | -0.02 | 0.01 | -0.03 | -430.23% |
| Q3 2022 Q2Q % growth | 0.01 1,201.69% | 0.00 | 0.01 | % |
| Q2 2022 Q2Q % growth | 0.00 -66.78% | 0.01 | -0.01 | -61.66% |
| Q1 2022 Q2Q % growth | 0.01 -62.26% | % | ||
| Q4 2021 Q2Q % growth | 0.00 -100.00% | 0.00 | 0.00 | % |
| Q3 2021 Q2Q % growth | 0.00 -110.09% | 0.00 | 0.00 | % |
| Q2 2021 Q2Q % growth | 0.01 -21.87% | 0.02 | -0.01 | -30.05% |
| Q1 2021 Q2Q % growth | 0.01 9.23% | 0.01 | 0.00 | -7.25% |
| Q4 2020 Q2Q % growth | 0.02 -22.23% | 0.01 | 0.01 | 76.63% |
| Q3 2020 Q2Q % growth | 0.01 -47.41% | 0.02 | -0.01 | -40.11% |
| Q2 2020 Q2Q % growth | 0.02 37.22% | 0.02 | 0.00 | 2.61% |
| Q1 2020 Q2Q % growth | 0.01 6.78% | 0.02 | -0.01 | -38.37% |
| Q4 2019 Q2Q % growth | 0.02 -12.63% | 0.02 | 0.00 | 29.60% |
| Q3 2019 Q2Q % growth | 0.02 139.03% | 0.01 | 0.01 | 80.46% |
| Q2 2019 Q2Q % growth | 0.01 -5.71% | 0.01 | 0.00 | -15.35% |
| Q1 2019 Q2Q % growth | 0.01 54.14% | 0.01 | 0.00 | 8.34% |
| Q4 2018 Q2Q % growth | 0.02 | 0.02 | 0.00 | 25.76% |
| Q3 2018 Q2Q % growth | 0.01 | 0.01 | 0.00 | 3.43% |
| Q2 2018 Q2Q % growth | 0.01 | 0.01 | 0.00 | 23.01% |
| Q1 2018 Q2Q % growth | 0.01 | 0.01 | 0.00 | 15.41% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 74.849M 12.28% | 79.238M | -4.389M | -5.54% |
| Q2 2024 Q2Q % growth | 74.093M 34.97% | 76.668M | -2.575M | -3.36% |
| Q1 2024 Q2Q % growth | 55.586M 30.66% | 70.478M | -14.892M | -21.13% |
| Q4 2023 Q2Q % growth | 81.217M 48.69% | 74.933M | 6.284M | 8.39% |
| Q3 2023 Q2Q % growth | 66.661M 22.90% | 63.18M | 3.481M | 5.51% |
| Q2 2023 Q2Q % growth | 54.897M 9.47% | 54.363M | 534K | 0.98% |
| Q1 2023 Q2Q % growth | 42.541M -8.74% | 49.595M | -7.054M | -14.22% |
| Q4 2022 Q2Q % growth | 54.621M -72.53% | 61.724M | -7.103M | -11.51% |
| Q3 2022 Q2Q % growth | 54.238M 2.60% | 55.62M | -1.382M | -2.48% |
| Q2 2022 Q2Q % growth | 50.146M 0.95% | 53.198M | -3.052M | -5.74% |
| Q1 2022 Q2Q % growth | 46.617M 18.92% | % | ||
| Q4 2021 Q2Q % growth | 198.871M -6.27% | 57.508M | 141.363M | 245.81% |
| Q3 2021 Q2Q % growth | 52.864M 14.62% | 55.686M | -2.822M | -5.07% |
| Q2 2021 Q2Q % growth | 49.673M 26.40% | 69.371M | -19.698M | -28.40% |
| Q1 2021 Q2Q % growth | 39.199M -20.48% | 63.237M | -24.038M | -38.01% |
| Q4 2020 Q2Q % growth | 212.174M 364.64% | 62.49M | 149.684M | 239.53% |
| Q3 2020 Q2Q % growth | 46.121M 1.54% | 56.991M | -10.87M | -19.07% |
| Q2 2020 Q2Q % growth | 39.299M -7.99% | 59.743M | -20.444M | -34.22% |
| Q1 2020 Q2Q % growth | 49.294M 39.94% | 54.624M | -5.33M | -9.76% |
| Q4 2019 Q2Q % growth | 45.664M 23.92% | 52.989M | -7.325M | -13.82% |
| Q3 2019 Q2Q % growth | 45.423M -53.78% | 50.724M | -5.301M | -10.45% |
| Q2 2019 Q2Q % growth | 42.711M 42.51% | 44.837M | -2.126M | -4.74% |
| Q1 2019 Q2Q % growth | 35.224M 19.48% | 43.01M | -7.786M | -18.10% |
| Q4 2018 Q2Q % growth | 36.85M | 44.367M | -7.517M | -16.94% |
| Q3 2018 Q2Q % growth | 98.28M | 38.022M | 60.258M | 158.48% |
| Q2 2018 Q2Q % growth | 29.97M | 38.742M | -8.772M | -22.64% |
| Q1 2018 Q2Q % growth | 29.48M | 35.853M | -6.373M | -17.78% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 125% | 0% | -77.83% |
| Revenue | 0% | 3.98% | 0% | -3.06% |